You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

Claims for Patent: 7,202,356


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,202,356
Title:Fructose-bisphosphate aldolase regulatory sequences for gene expression in oleaginous yeast
Abstract: The regulatory sequences (i.e., promoter regions, introns and enhancers) associated with the Yarrowia lipolytica gene encoding fructose bis-phospate aldolase (FBA1) have been found to be particularly effective for the expression of heterologus genes in oleaginous yeast. The promoter regions of the invention have been shown to drive high-level expression of genes involved in the production of .omega.-3 and .omega.-6 fatty acids.
Inventor(s): Pollak; Dana M. Walters (Media, PA), Zhu; Quinn Qun (West Chester, PA)
Assignee: E. I. du Pont de Nemours and Company (Wilmington, DE)
Application Number:10/987,548
Patent Claims:1. A method for the expression of a coding region of interest in a transformed yeast cell comprising: (a) providing a transformed yeast cell having a chimeric gene comprising: (i) a regulatory sequence of the Yarrowia fba1 gene; and, (ii) a coding region of interest expressible in the yeast cell; wherein the regulatory sequence is operably linked to the coding region of interest; and (b) growing the transformed yeast cell of step (a) under conditions whereby the chimeric gene of step (a) is expressed.

2. A method according to claim 1 wherein the regulatory sequence of the Yarrowia fba1 gene is selected from the group consisting of: a FBA promoter region; a FBAIN promoter region; a FBAINm promoter region; and a chimeric promoter comprising the fba1 intron.

3. A method according to claim 1 wherein the regulatory sequence of the Yarrowia fba1 gene is isolated from Yarrowia lipolytica.

4. A method according to claim 1 wherein the transformed yeast cell is an oleaginous yeast.

5. A method of claim 4, wherein the oleaginous yeast is a member of a genus selected from the group consisting of Yarrowia, Candida, Rhodotorula, Rhodosporidium, Cryptococcus, Trichosporon and Lipomyces.

6. A method according to claim 1 wherein the coding region of interest encodes a polypeptide selected from the group consisting of: desaturases, elongases, acyltransferases, aminopeptidases, amylases, carbohydrases, carboxypeptidases, catalyases, cellulases, chitinases, cutinases, cyclodextrin glycosyltransferases, deoxyribonucleases, esterases, .alpha.-galactosidases, .beta.-galactosidases, glucoamylases, .alpha.-glucosidases, .beta.-glucanases, .beta.-glucosidases, invertases, laccases, lipases, mannosidases, mutanases, oxidases, pectinolytic enzymes, peroxidases, phospholipases, phytases, polyphenoloxidases, proteolytic enzymes, ribonucleases, trausglutaminases and xylanases.

7. A plasmid comprising a regulatory sequence of a Yarrowia fab1 gene selected from the group consisting of a FBA promoter region, FBAIN promoter region and an FBAINm promoter region.

8. A plasmid comprising fba1 intron of a Yarrowia fab1 gene.

Details for Patent 7,202,356

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 06/04/1986 ⤷  Try a Trial 2023-11-14
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 ⤷  Try a Trial 2023-11-14
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b Injection 103132 ⤷  Try a Trial 2023-11-14
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.